![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 2-thiophenepropanoic Acid, Alpha-((2-butyl-1-((4- Carboxyphenyl)methyl)-lh-imidazol-5-yl)methylene)-, (e)-
2. Eprosartan
3. Sk And F 108566
4. Skf-108566
5. Teveten
1. 144143-96-4
2. Teveten
3. Eprosartan Mesilate
4. Eprosartan Methanesulfonate
5. Eprosartan Monomethanesulfonate
6. Eprosartan (mesylate)
7. Sk&f 108566-j
8. Sk&f-108566-j
9. 8n2l1nx8s3
10. Chebi:48409
11. (e)-2-butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate
12. 4-[[2-butyl-5-[(e)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic Acid;methanesulfonic Acid
13. Eprosartan Mesylate (usan)
14. Dsstox_cid_24217
15. Dsstox_rid_80124
16. Dsstox_gsid_44217
17. Eprosartan Mesylate [usan]
18. 4-({2-butyl-5-[(1e)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1h-imidazol-1-yl}methyl)benzoic Acid; Methanesulfonic Acid
19. Cas-144143-96-4
20. Eprosartan Mesylate [usan:ban]
21. Ncgc00164557-01
22. Unii-8n2l1nx8s3
23. Futuran
24. Navixen
25. Regulaten
26. Tevetenz
27. Epro-sartan Mesylate Dihydrate
28. Sr-05000001450
29. Eprosartanmesylate
30. Teveten Sb
31. Skf-108566j
32. Teveten (tn)
33. Schembl41396
34. Chembl1200987
35. Dtxsid7044217
36. Hms3262b17
37. Hms3885b05
38. Eprosartan Mesylate [vandf]
39. Eprosartan Mesilate [mart.]
40. Tox21_112186
41. Tox21_500808
42. Eprosartan Mesilate [who-dd]
43. Eprosartan Mesylate [usp-rs]
44. Hy-15834a
45. Mfcd08141807
46. S4102
47. Akos015994738
48. Eprosartan Mesylate, >=98% (hplc)
49. Tox21_112186_1
50. Am84399
51. Ccg-222112
52. Ks-1233
53. Eprosartan Mesylate [orange Book]
54. Ncgc00167505-02
55. Ncgc00261493-01
56. (e)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1h-imidazol-1-yl)methyl)benzoic Acid Compound With Methanesulfonic Acid (1:1)
57. 2-thiophenepropanoic Acid, Alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulfonate
58. Eprosartan Mesylate [usp Monograph]
59. Eprosartan Monomethanesulfonate [mi]
60. E-145
61. E1161
62. Sw219286-1
63. A13747
64. D02082
65. Teveten Hct Component Eprosartan Mesylate
66. 143e964
67. A808180
68. Eprosartan Mesylate Component Of Teveten Hct
69. J-007923
70. Sr-05000001450-2
71. Q27121190
72. Eprosartan Mesylate, United States Pharmacopeia (usp) Reference Standard
73. (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate
74. (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic Acid, Monomethanesulphonate
75. (e)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1h-imidazol-1-yl)methyl)benzoic Acid Methanesulfonic Acid Salt
76. (e)-alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-2-thiophenepropanoic Acid Monomethanesulfonate
77. 2-thiophenepropanoic Acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulfonate
78. 2-thiophenepropanoic Acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulphonate
79. 2-thiophenepropanoic Acid, Alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-, (alphae)-, Methanesulfonate (1:1)
80. 4-({2-butyl-5-[(1e)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1h-imidazol-1-yl}methyl)benzoic Acid Methanesulfonate
81. 4-[[2-butyl-5-[(e)-2-carboxy-3-(2-thienyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic Acid; Methanesulfonic Acid
82. 4-[[2-butyl-5-[(e)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic Acid;methanesulfonic Acid.
83. Eprosartan Mesylate
84. Sk&f 108566
85. (?e)-?-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid Methanesulfonate
Molecular Weight | 520.6 g/mol |
---|---|
Molecular Formula | C24H28N2O7S2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 10 |
Exact Mass | 520.13379358 g/mol |
Monoisotopic Mass | 520.13379358 g/mol |
Topological Polar Surface Area | 183 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 711 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Eprosartan mesylate |
PubMed Health | Eprosartan (By mouth) |
Drug Classes | Cardiovascular Agent, Renal Protective Agent |
Drug Label | TEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl... |
Active Ingredient | Eprosartan mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Mylan Pharms |
2 of 4 | |
---|---|
Drug Name | Teveten |
Drug Label | TEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl... |
Active Ingredient | Eprosartan mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Abbvie |
3 of 4 | |
---|---|
Drug Name | Eprosartan mesylate |
PubMed Health | Eprosartan (By mouth) |
Drug Classes | Cardiovascular Agent, Renal Protective Agent |
Drug Label | TEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl... |
Active Ingredient | Eprosartan mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Mylan Pharms |
4 of 4 | |
---|---|
Drug Name | Teveten |
Drug Label | TEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl... |
Active Ingredient | Eprosartan mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Abbvie |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Angiotensin II Type 2 Receptor Blockers
Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR. (See all compounds classified as Angiotensin II Type 2 Receptor Blockers.)